[Studies on re-immunization with live attenuated hepatitis A vaccine]

Area of Science:

• Immunology
• Vaccinology
• Hepatology

Context:

• Hepatitis A (HA) remains a public health concern, necessitating effective vaccination strategies.
• Understanding the immune response to live attenuated HA vaccines is crucial for optimizing immunization schedules.
• Assessing the efficacy of booster doses in children with varying primary immunization histories is important.

Purpose:

• To investigate the immunogenicity of a booster dose of live attenuated hepatitis A (HA) vaccine.
• To compare the antibody response after re-immunization versus primary immunization and natural infection.
• To evaluate the impact of prior HA vaccination status on the response to a booster dose.

Summary:

• Re-immunization with live attenuated HA vaccine led to a rapid increase in anti-HAV antibodies and geometric mean titer (GMT).
• The immune response to re-immunization varied based on prior immunization history, with significantly higher seroconversion rates in previously non-responsive children.
• A modified Abbott enzyme immunoassay (EIA) may underestimate the primary immune response, suggesting a need for more sensitive detection methods.

Impact:

• Re-immunization can effectively boost immunity in children, particularly those with suboptimal responses to primary vaccination.
• Findings highlight the importance of considering primary immunization history when evaluating vaccine effectiveness and persistence.
• The study underscores the need for sensitive assays to accurately assess immune responses to HA vaccination.